This up-to-the-minute Second Edition of an incomparable resource describes in detail the bases for developing dosage forms for use in animals-highlighting the data necessary to meet regulatory approval.
Demonstrates the successful characterization, control, and registration of new veterinary medicines!
Thoroughly rewritten and enlarged to reflect the technical advances that have occurred since the previous edition, Development and Formulation of Veterinary Dosage Forms, Second Edition
discusses the reasons for dosage form selection
explains the latest available technologies
examines new drug therapeutics
reveals up-to-date techniques and applications for pharmacokinetic data
covers the formulation of products derived from biotechnology
elucidates recent analytical methods
shows how to determine the type of dosage form appropriate for particular species
Written by a team of international authorities from North America and Europe and containing over 1100 bibliographic citation, figures, and tables, Development and Formulation of Veterinary Dosage Forms, Second Edition is an essential reference for pharmaceutical, animal, and quality control scientists; research pharmacists and pharmacologists; veterinarians; drug quality assurance and regulatory personnel in government and industry; pathologists; microbiologists; virologists; physiologists; toxicologists; and upper-level undergraduate and graduate students in these disciplines.
Table of Contents
Introduction: Veterinary Drug Availability, Gerald B. Guest
Basis for Selection of the Dosage Form, J. Desmond Baggot and Scott A. Brown
Formulation of Veterinary Dosage Forms, Paul R. Klink, Thomas H. Ferguson, and Judy A. Magruder
Protein/Peptide Veterinary Formulations, Todd P. Foster
Formulation of Vaccines, Russell Bey, Randy Simonson, and Nathalie Garcon
Administration Devices and Techniques, David W. Cook
Specification Development and Stability Assessment, Gary R. Dukes and David A. Hahn
Bioavailability Bioequivalence Assessments, Marilyn N. Martinez and Melanie R. Berson
Design of Preclinical Studies, Gary Olaf Korsrud, Gérard Lambert, James D. MacNeil, and Man Sen Yon